Patents Assigned to Ascensia Diabetes Care Holdings AG
  • Patent number: 10662264
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: May 26, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 10656112
    Abstract: A blood glucose monitor includes a can, a replaceable sensor cartridge that includes a frame, an upper spring disposed between the frame and the can, a case for housing the can and sealing the frame, a lower spring disposed between the can and the case, and a meter housing for sealing an upper portion of the frame. The can is capable of accepting the replaceable sensor cartridge. The frame of the removable cartridge has at least at least two walls defining a chamber for accepting a plurality of biosensors, and a bottom portion defining an opening and at least one sealing flange. The frame can further include a desiccant material capable of reducing humidity within the frame. The frame may be dimensioned such that an interference fit constrains the plurality of biosensors prior to inserting the frame within a blood glucose monitor.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: May 19, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jeffery S. Reynolds, Robert S. Sams, Simin Yao, Eugene Prais, Michael A. Botta, Steven C. Charlton, Mirza Kokic
  • Patent number: 10655004
    Abstract: An electrochemical sensor system comprises an electrochemical sensor and a hydrogel composition. The electrochemical sensor has at least a counter electrode and a working electrode. The hydrogel composition contacts the working electrode. The hydrogel composition comprises a first monomer, a second monomer, a cross-linking agent, and a solvent. The first monomer has hydrophilic characteristics. The second monomer has hydrophobic characteristics. The ratio of the first monomer to the second monomer is from about 0.1:99.9 to about 99.9:0.1.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: May 19, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Paul Valint, Jr., Doug H. Williamson, Boru Zhu
  • Patent number: 10656113
    Abstract: A biosensor system determines analyte concentration from an output signal generated from a light-identifiable species or a redox reaction of the analyte. The biosensor system adjusts a correlation for determining analyte concentrations from output signals or determined analyte concentrations with one or more complex index function extracted from the output signals or from other sources. The complex index functions determine at least one slope deviation value, ?S, or normalized slope deviation from one or more error parameters. The slope-adjusted correlation between analyte concentrations and output signals may be used to determine analyte concentrations having improved accuracy and/or precision from output signals including components attributable to bias.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: May 19, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Sung-Kwon Jung
  • Patent number: 10646150
    Abstract: A lancing device having a domed structure that can be depressed by application of a force by a user's finger so as to expose the tip of a needle. The domed structure is configured to move from a non-depressed state to a depressed state in a manner that allows for the piercing the users finger. The domed structure may then recoil to its original, non-depressed position upon the user ceasing to apply the force.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: May 12, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Eugene Prais, Robert S. Sams, Simin Yao
  • Patent number: 10647846
    Abstract: An electrochemical sensor system comprises an electrochemical sensor and a hydrogel composition. The electrochemical sensor has at least a counter electrode and a working electrode. The hydrogel composition contacts the working electrode. The hydrogel composition comprises a first monomer, a second monomer, a cross-linking agent, and a solvent. The first monomer has hydrophilic characteristics. The second monomer has hydrophobic characteristics. The ratio of the first monomer to the second monomer is from about 0.1:99.9 to about 99.9:0.1.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: May 12, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Paul Valint, Doug H. Williamson, Boru Zhu
  • Patent number: 10646445
    Abstract: A biosensor system determines analyte concentration from an output signal generated from a light-identifiable species or a redox reaction of the analyte. The biosensor system compensates at least 50% of the total error in the output signal with a primary function and may compensate a portion of the residual error with at least one residual function. An SSP function may serve as the primary function, first residual function, or second residual function. Preferably, when the SSP function serves as the first residual function, the SSP function compensates at least 50% of the residual error remaining after primary compensation. Preferably, when the SSP function serves as the second residual function, the SSP function compensates at least 50% of the residual error remaining after primary and first residual compensation. The error compensation provided by the primary, first residual, and second residual functions may be adjusted with function weighing coefficients.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: May 12, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Huan-Ping Wu
  • Patent number: 10591436
    Abstract: A biosensor system determines analyte concentration from an output signal generated from a light-identifiable species or a redox reaction of the analyte. The biosensor system compensates at least 50% of the total error in the output signal with a primary function and compensates a portion of the remaining error with a residual function. The amount of error compensation provided by the primary and residual functions may be adjusted with a weighing coefficient. The compensation method including a primary function and a residual function may be used to determine analyte concentrations having improved accuracy from output signals including components attributable to error.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: March 17, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Bern Harrison, Eric Maurer
  • Patent number: 10585059
    Abstract: An electrochemical test sensor for detecting the concentration of an analyte in a fluid sample. The electrochemical test sensor includes a housing that has a first end and a second opposing end. The housing includes an opening at the first end to receive a fluid test sample. An electrode assembly includes a substrate, a working electrode, a counter electrode and a reagent. The substrate has a first surface and an opposing second surface. The working electrode is disposed on the first surface of the substrate, and the counter electrode is disposed on the second surface of the substrate. The electrode assembly is positioned within the housing to define a reaction channel. The electrochemical test sensor may be used with a removable lancet mechanism or integrated within a lancet mechanism to form one integral unit.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: March 10, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Yuan Wang, Raeann Gifford, Hualin Jiang, Jeffery S. Reynolds, Jiangfeng Fei
  • Patent number: 10582361
    Abstract: Some embodiments of the present invention include pairing two wireless devices by placing at least one of two devices in a pairing mode; performing at least one pairing motion event with at least one of the wireless devices to satisfy at least one pairing condition; detecting satisfaction of the at least one pairing condition; and pairing the two wireless devices in response to detecting satisfaction of the at least one pairing condition. Numerous other aspects are provided.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: March 3, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Qiang Fu, Alexander Markovic, Joseph R. Anstett, Jr., Vladislav Milenkovic
  • Patent number: 10548537
    Abstract: A testing system and method for providing a testing system includes a user interface having a display for displaying information relating to measurements of health data and an input device for receiving information from a user relating to the health data. Provided in connection with the user interface is an autologging feature adapted to provide the user with user-selectable options on the display. Also provided is a statistical operation adapted to provide the user with enhanced information relating to the measurements of health data. Also provided is at least one indicator for indicating information relating to the number of health data readings that are within a target range, the number of health data readings that are above the target range and the number of health data readings that are below the target range.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: February 4, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Jacob Brauer, Darren Brown, Jun Chen, Richard Kates, Jennifer M. Levin, Harris Lieber, Amy Schwartz, Raymond Yao
  • Patent number: 10546482
    Abstract: A method for using a meter and a meter (10) adapted to determine an analyte concentration reading, the meter comprising a display (12) adapted to display information to a user of the meter, the display including information directed to a post-meal test-time alarm (22?) that is adapted to remind the user to obtain a post-meal analyte concentration reading, and at least one user input mechanism (15) adapted to allow the user to activate the post-meal test-time alarm.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: January 28, 2020
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Barry D. Power, Jeffrey A. Culver
  • Patent number: 10533949
    Abstract: The present invention relates to a system, method, and meter for determining the concentration of an analyte in a fluid sample provided on a test strip. The meter (10) may include a body (12), an optical reader (28), and a test strip holder (90). The body (12) has first (14) and second ends (16) and defines a longitudinal axis y extending between the first and second ends (14,16). The optical reader (28) may be coupled to the body (12) and adapted to analyze the analyte on the test strip. The test strip holder (90) may be coupled to the body (12) and include first and second arms (92,94). One of the optical reader (28) or the test strip holder (90) may be movable along the longitudinal axis of the body between a first position, in which the first and second arms (92,94) of the test strip holder (90) overlie the optical reader (28), and a second position, in which the optical reader (28) extends beyond the first and second arms (92,94) of the test strip holder (90).
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: January 14, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Steven C. Charlton
  • Patent number: 10503876
    Abstract: Embodiments of the invention provide systems, methods, and apparatus for attaching an automated dose setting apparatus to a medication delivery device, receiving a first signal from an analyte monitoring system, the first signal indicating a dose of medication to be administered, and driving a dose knob of the medication delivery device with the automated dose setting apparatus to set a dose corresponding with the dose of medication to be administered. Numerous other aspects are disclosed.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: December 10, 2019
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Igor Y. Gofman, Jun Chen, James A. Johnson
  • Patent number: 10488395
    Abstract: A test sensor (100) for determining an analyte concentration in a biological fluid comprises a strip including a fluid receiving area (128) and a port-insertion region (126). A first row of optically transparent (132) and non-transparent positions forms a calibration code pattern (130) disposed within a first area of the port-insertion region (126). A second row of optically transparent (142) and non-transparent positions forms a synchronization code pattern (140) disposed within a second area of the port-insertion region (126). The second area is different from the first area. The synchronization code pattern (140) corresponds to the calibration code pattern (130) such that the synchronization code pattern (140) provides synchronization of the serial calibration code pattern (130) during insertion of the port-insertion region (126) into the receiving port of the analyte meter.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: November 26, 2019
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Igor Gofman
  • Patent number: 10478103
    Abstract: Embodiments of the invention provide apparatus, systems, and methods wherein pre-event and post-event analyte concentration readings associated with an event are collected and processed to determine a numerical delta. The numerical delta may be displayed on a visual display to aid in a ready determination of the affect that the event (alone or in combination with medication and/or insulin dosages) had on the analyte concentration levels. Medication and/or insulin dosages may be displayed alongside the numerical delta to gauge immediate relationships between numerical delta, dosage, and/or an associated event. Apparatus and systems for calculating and displaying the numerical delta are described, as are other aspects.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: November 19, 2019
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: David A. Simmons, Jeffery S. Reynolds, Paul M. Ripley, Stanley A. Telson
  • Patent number: 10481013
    Abstract: A system and method for rapidly determining ambient temperature in a fluid-analyte meter. The meter includes a housing defining an interior space and an area for receiving a fluid sample. A processor and a first temperature sensor are disposed within the interior space of said the housing. A second temperature sensor is disposed on the housing. One or more processors are configured to determine a first temperature value from temperature data received from the first temperature sensor. The processor(s) are also configured to apply a variable current to a temperature-adjustment source such that the second temperature sensor is adjusted to a predetermined steady-state temperature value different from the first temperature value. The processor(s) are further configured to determine an ambient temperature of an exterior space of the housing based on the applied variable current, pre-determined steady-state temperature, and received first temperature values.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: November 19, 2019
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventor: Mu Wu
  • Patent number: 10468127
    Abstract: A portable data-management system may be easily employed with multiple processing devices by eliminating the need to pre-install additional programs, agents, device drivers, or other software components on the hosts. A portable storage device contains software for a data-management application, which receives and processes test data from a meter that measures an analyte. The portable device may employ an interface protocol that makes the portable device immediately compatible with different operating systems and hardware configurations. Once the portable device is connected to the host, the data-management application can be automatically launched. The convenience and portability of a data-management system may be enhanced by integrating advanced data processing and display features with the portable device. The users may access some advanced presentations of health data without having to launch the data-management application on a separate host.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: November 5, 2019
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Darren Brown, Jun Chen, Igor Gofman, Steven B. Harris, Paul L. Inman, Richard Kates, Qiong Li, Harris Lieber, Paul M. Ripley, Gregory Stefkovic, Hoi-Cheong Steve Sun, Mu Wu, Raymond Yao, Simin Yao
  • Patent number: 10457971
    Abstract: A method of making an electrochemical sensor strip that includes: depositing a first electrode on a base; depositing a second electrode on the base; applying a first layer onto the first electrode; and applying a second layer onto the second electrode. The first layer includes an oxidoreductase and a mediator. The second layer includes a soluble redox species.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: October 29, 2019
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Huan-Ping Wu, Greg P. Beer, Christina Blaschke
  • Patent number: 10444178
    Abstract: A sensor system including devices and methods for determining the concentration of an analyte in a sample is described. Input signals including amperometric and voltammetric duty cycles of excitations and relaxations may provide a shorter analysis time and/or improve the accuracy and/or precision of the analysis. The disclosed system may reduce analysis errors, thus improving measurement performance, by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The disclosed system also may determine the concentration of more than one ionizable species in the sample by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The multiple, determined concentrations may be used to determine the concentration of multiple analytes or to correct the concentration determined for an analyte, thus improving the measurement performance of the system.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: October 15, 2019
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventor: Huan-Ping Wu